Australia markets open in 2 hours 13 minutes

Nuheara Limited (NUH.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.16000.0000 (0.00%)
At close: 04:10PM AEST
Full screen
Previous close0.1600
Bid0.1550 x 197574900
Ask0.1600 x 26031200
Day's range0.1500 - 0.1600
52-week range0.1000 - 0.9800
Avg. volume190,658
Market cap16.512M
Beta (5Y monthly)1.94
PE ratio (TTM)N/A
EPS (TTM)-0.1390
Earnings date16 Aug 2022 - 22 Aug 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Nuheara Announces New US-Based CEO and Engagement of Roth Capital Partners to Explore US Listing

    BELLEVUE, Wash., May 09, 2022 (GLOBE NEWSWIRE) -- Medical device manufacturer, Nuheara Limited (ASX:NUH) (Company or Nuheara) is pleased to announce a series of structural changes designed to advance the Company’s unique and growing US based hearing healthcare market opportunities: The appointment of John R. Luna as its global, US based, Chief Executive Officer;Co-founder and former CEO, Justin Miller, remaining as the Company’s Managing Director;Engagement of Roth Capital Partners LLC (“Roth”)

  • GlobeNewswire

    Nuheara Submits 510(k) for U.S. FDA Clearance

    BELLEVUE, Wash., April 12, 2022 (GLOBE NEWSWIRE) -- Nuheara Limited (ASX:NUH) (Company or Nuheara) has taken the final step in its plans to secure U.S. Food and Drug Administration (FDA) clearance for its self-fitting hearing aid by providing its 510(k) submission to the FDA. This follows completion of Nuheara’s successful clinical trial by National Acoustic Laboratories (NAL) in January 2022. The trial successfully validated the effectiveness of the Nuheara self-fitted hearing aids compared to

  • Simply Wall St.

    We're Keeping An Eye On Nuheara's (ASX:NUH) Cash Burn Rate

    There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...